Kymanox Acquires EU Based Anteris Medical and Anteris Helvetia

Interview: Kymanox Executive Advisors Mathias Romacker, Fran DeGrazio & Paul Jansen

Growing Happy Cells: Bioreactor Optimization

Playing the Long Game: Benefits of Investing Now in Meeting New Annex 1 Requirements

The Top 10 Most Cited QSR Clauses In FDA FY2022 Medical Device Inspections

NEUMA, the Design and Testing Arm of Kymanox, Moves To New Headquarters

4 Key Takeaways For Combination Products As We Move Into 2023

Mathias Romacker Selected as the Newest Member of the Kymanox Executive Advisor Team